Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

TTOO Stock Alert: T2 Reschedules Annual Meeting to Sept. 15

By Eddie Pan, InvestorPlace Financial News Writer
TTOO stock is in focus after the company announced that it would postpone its annual meeting of stockholders to Sept. 15.

7 Standout Blue-Chip Stocks That Will Outlast Everything

By Omor Ibne Ehsan
No matter how harsh the environment gets, these blue-chip stocks have fortress balance sheets and sticky businesses that can withstand anything.

Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?

By William White, InvestorPlace Writer
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.

Why Is Calidi Biotherapeutics (CLDI) Stock Down 36% Today?

By William White, InvestorPlace Writer
Calidi Biotherapeutics (CLDI) stock is taking a beating on Wednesday following the clinical-stage biotechnology company's public debut.

3 Top Growth Stock Picks Trading at a Massive Bargain

By Omor Ibne Ehsan
These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months.

Why Is Avalo Therapeutics (AVTX) Stock Up 69% Today?

By William White, InvestorPlace Writer
Avalo Therapeutics (AVTX) stock is taking off on Wednesday after the biotechnology company announced a $45 million asset sale.

Why Is Novo Nordisk (NVO) Stock Up 95% Today?

By William White, InvestorPlace Writer
Novo Nordisk (NVO) stock is on the rise Wednesday after the pharmaceutical company announced an upcoming split of its shares.

3 Overlooked High-Yield Stocks Trading at a P/E of Less Than 10

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued high-yield stocks to buy and hold for robust total returns in the next 24 months.

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor
While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

3 Biotech Blockbusters to Turn $5,000 Into $50,000

By Omor Ibne Ehsan
These transformative early-stage biotech stocks can deliver triple-digit upside if their key milestones are achieved on time.

Why Is Geron (GERN) Stock Up Today?

By William White, InvestorPlace Writer
Geron (GERN) stock is gaining on Tuesday following an upgrade for the biopharmaceutical company's shares from Goldman Sachs.

Why Is Acelyrin (SLRN) Stock Down 58% Today?

By William White, InvestorPlace Writer
Acelyrin (SLRN) stock is falling hard on Tuesday after the biopharma company announced lackluster clinical trial results.

7 No-Brainer Stocks to Buy With $1000 Right Now

By Muslim Farooque, InvestorPlace Contributor
Consider these stocks to buy under $1000, providing investors with promising long-term growth potential ahead

The 3 Most Undervalued Cheap Stocks to Buy in September 2023

By Michael Que, InvestorPlace Contributor
These cheap stocks to buy are the ones for long term growth and high returns in your investment portfolio.

Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold

By Joel Baglole, InvestorPlace Contributor
Excitement is building around the potential health and financial benefits of these new weight-loss medications.

3 Penny Stocks to Sell in September Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor
Some penny stocks go on to deliver huge returns for their owners. Most, however, do not. After all, companies usually end up in penny stock…

The Fun Is Over for TTOO Stock… At Least for Now

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
T2 Biosystem's reverse stock split doesn't bode well for the company. And TTOO stock investors shouldn't stick around.

Dear CGC Stock Fans, Mark Your Calendars for Sept. 25

By William White, InvestorPlace Writer
Canopy Growth (CGC) stock fans will want to check in on the company when Sept. 25 rolls around for a potential catalyst.

Why Is Nuwellis (NUWE) Stock Down Today?

By William White, InvestorPlace Writer
Nuwellis (NUWE) stock is taking a beating on Monday despite a lack of news or increased trading activity for the medical device company.
Load More Articles